@santhoshibavi.bsky.social
Reposted
This also makes for interesting reading
www.nephjc.com/news/2017/4/...
Rodby and I had quite a fun argument
The RushRenalRules are to pay eternal homage to ACEi
#NephJC
www.nephjc.com/news/2017/4/...
Rodby and I had quite a fun argument
The RushRenalRules are to pay eternal homage to ACEi
#NephJC
ACEi, ARBs the Change in Creatinine, and the Future Risk of Outcomes — NephJC
ACEi, ARBs, the increase in creatinine and health outcomes: Now for some retrospective data.
www.nephjc.com
December 18, 2024 at 2:06 AM
This also makes for interesting reading
www.nephjc.com/news/2017/4/...
Rodby and I had quite a fun argument
The RushRenalRules are to pay eternal homage to ACEi
#NephJC
www.nephjc.com/news/2017/4/...
Rodby and I had quite a fun argument
The RushRenalRules are to pay eternal homage to ACEi
#NephJC
Reposted
T0e: STOP-ACEi was a multicenter, open-label trial that randomized 411 patients with advanced CKD to continue or discontinue therapy with RASi, with a follow-up of 3 yrs
STOP-ACEi trial did not find any benefit of stopping ACEi/ARBs in advanced CKD #NephJC
www.nephjc.com/news/...
STOP-ACEi trial did not find any benefit of stopping ACEi/ARBs in advanced CKD #NephJC
www.nephjc.com/news/...
December 18, 2024 at 2:11 AM
T0e: STOP-ACEi was a multicenter, open-label trial that randomized 411 patients with advanced CKD to continue or discontinue therapy with RASi, with a follow-up of 3 yrs
STOP-ACEi trial did not find any benefit of stopping ACEi/ARBs in advanced CKD #NephJC
www.nephjc.com/news/...
STOP-ACEi trial did not find any benefit of stopping ACEi/ARBs in advanced CKD #NephJC
www.nephjc.com/news/...
Reposted
T0b:
Renin-angiotensin inhibition (RASi) use is challenging in patients with advanced stages of CKD
😱The fear of hyperkalemia or overall worsening of CKD makes some clinicians moderate or terminate their use of RASi in CKD 4/5
Infographic by @priti899.bsky.social
#NephJC
Renin-angiotensin inhibition (RASi) use is challenging in patients with advanced stages of CKD
😱The fear of hyperkalemia or overall worsening of CKD makes some clinicians moderate or terminate their use of RASi in CKD 4/5
Infographic by @priti899.bsky.social
#NephJC
December 18, 2024 at 2:08 AM
T0b:
Renin-angiotensin inhibition (RASi) use is challenging in patients with advanced stages of CKD
😱The fear of hyperkalemia or overall worsening of CKD makes some clinicians moderate or terminate their use of RASi in CKD 4/5
Infographic by @priti899.bsky.social
#NephJC
Renin-angiotensin inhibition (RASi) use is challenging in patients with advanced stages of CKD
😱The fear of hyperkalemia or overall worsening of CKD makes some clinicians moderate or terminate their use of RASi in CKD 4/5
Infographic by @priti899.bsky.social
#NephJC
Reposted
👀 ¿Qué papel juegan los IECA/ARA-II en la ERC avanzada? Revisa el VA creado por @drnikhil.bsky.social, traducir por @dramiliflores.bsky.social
#NephJC
www.nephjc.com/news/...
#NephJC
www.nephjc.com/news/...
December 18, 2024 at 2:04 AM
👀 ¿Qué papel juegan los IECA/ARA-II en la ERC avanzada? Revisa el VA creado por @drnikhil.bsky.social, traducir por @dramiliflores.bsky.social
#NephJC
www.nephjc.com/news/...
#NephJC
www.nephjc.com/news/...